Understanding the role of sex hormones in cancer for the transgender community

Trends in Cancer - Tập 8 - Trang 273-275 - 2022
Sarah S. Jackson1, Kate Z. Nambiar2,3, Stewart O’Callaghan4, Alison May Berner5,6
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA
2Brighton & Sussex University Hospitals NHS Trust, Brighton, UK
3Welsh Gender Service, Cardiff and Vale University Health Board, Cardiff, UK
4Live Through This Charity, London, UK
5Barts Cancer Institute, Queen Mary University of London, London, UK
6Gender Identity Clinic, Tavistock and Portman NHS Foundation Trust, London, UK

Tài liệu tham khảo

Clocchiatti, 2016, Sexual dimorphism in cancer, Nat. Rev. Cancer, 16, 330, 10.1038/nrc.2016.30 Patel, 2020, Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review, Endocrine, 68, 6, 10.1007/s12020-020-02197-5 Tin Tin, 2021, Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank, Br. J. Cancer, 125, 126, 10.1038/s41416-021-01392-z De Blok, 2019, Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands, BMJ, 365, 1652, 10.1136/bmj.l1652 Watts, 2018, Low free testosterone and prostate cancer risk: a collaborative analysis of 20 prospective studies, Eur. Urol., 74, 585, 10.1016/j.eururo.2018.07.024 de Nie, 2020, Prostate cancer incidence under androgen deprivation: nationwide cohort study in trans women receiving hormone treatment, J. Clin. Endocrinol. Metab., 105, 3293, 10.1210/clinem/dgaa412 Nelson, 2014, Estrogen receptor beta in prostate cancer: friend or foe?, Endocr. Relat. Cancer, 21, T219, 10.1530/ERC-13-0508 Giannandrea, 2013, Effect of endogenous and exogenous hormones on testicular cancer: the epidemiological evidence, Int. J. Dev. Biol., 57, 255, 10.1387/ijdb.130015fg de Nie, 2021, Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study, BJU Int. Harris, 2016, Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review, Fertil. Res. Pract., 2, 1, 10.1186/s40738-016-0029-2 de Blok, 2019, Cancer risk in transgender people, Endocrinol. Metab. Clin. N. Am., 48, 441, 10.1016/j.ecl.2019.02.005 Jackson, 2021, Cancer stage, treatment, and survival among transgender patients in the United States, J. Natl. Cancer Inst., 113, 1221, 10.1093/jnci/djab028 Jones, 2020, Inclusion of transgender and gender diverse health data in cancer biorepositories, Contemp. Clin. Trials Commun., 19, 10.1016/j.conctc.2020.100597 Vincent, 2018, Studying trans: recommendations for ethical recruitment and collaboration with transgender participants in academic research, Psychol. Sex., 9, 102 T’Sjoen, 2019, Endocrinology of transgender medicine, Endocr. Rev., 40, 97, 10.1210/er.2018-00011